What does the CHRNA5 (Smoking, Cognition) gene do?

CHRNA5 provides instructions for making part of a nicotinic acetylcholine receptor—one of the brain’s key receptor systems for acetylcholine signaling. These receptors also respond to nicotine, which can temporarily stimulate attention and alertness. Because CHRNA5 helps shape how strongly these receptors function, it can influence how the brain experiences nicotine and how reinforcing smoking may feel.

Why is the CHRNA5 (Smoking, Cognition) gene important?

CHRNA5 is important because certain variants in and around this gene (including nearby receptor genes in the same region) are linked in research to higher risk of heavy smoking and nicotine dependence, as well as smoking-related lung conditions such as COPD and lung cancer. Some of these variants are also associated with reduced cognitive performance. While nicotine can briefly boost cognition by activating these receptors, long-term smoking is associated with worsening brain and respiratory health—making CHRNA5 a valuable marker for understanding risk and supporting prevention or cessation strategies.

What can I do based on my CHRNA5 (Smoking, Cognition) results?

Based on your CHRNA5 (Smoking, Cognition) results, you’ll receive 1 personalized recommendation focused on drug-related guidance that can be taken to a clinician for shared decision-making. This may include genotype-informed considerations for smoking-cessation medications, guidance on when to seek medical support (especially if dependence risk appears elevated), and practical next steps to align treatment choices with your biology and health goals.

How is the CHRNA5 (Smoking, Cognition) gene linked to nicotine addiction and smoking intensity?

CHRNA5 affects the function of nicotinic acetylcholine receptors, which are activated by both acetylcholine (a natural brain messenger) and nicotine. Research has found that certain variants in the CHRNA5/CHRNA3 region are associated with heavier smoking and greater nicotine dependence. One proposed mechanism is that reduced receptor activity can blunt normal signaling, leading some individuals to seek more nicotine stimulation (for example, smoking more) to achieve the same perceived effect—raising dependence risk and increasing exposure to smoking-related toxins.

What do I learn from CHRNA5 (Smoking, Cognition) genetic testing in a DNA report?

A CHRNA5 DNA report identifies which versions (alleles) you carry at key SNPs studied in relation to smoking behavior, nicotine dependence, and cognitive outcomes. This report analyzes 4 variants and interprets them in a health context, helping you understand potential tendencies—such as higher likelihood of dependence or differences in cognitive impact associated with smoking. It also converts your genotype into 1 personalized, drug-focused recommendation you can discuss with a healthcare professional to support more individualized smoking-cessation planning.

Save $30

CHRNA5 (Smoking, Cognition)

Rated 4.70 out of 5 based on 10 customer ratings

4.7 (11 reviews)

CHRNA5 (Smoking, Cognition)

Rated 4.70 out of 5 based on 10 customer ratings

4.7 (11 reviews)

The report provides up to 1 personalized recommendations based on 4 genetic variants analyzed. Purchase a DNA kit to generate your genetic results. If you've already got one, you're all set to continue. View sample report.

$59

$29

Save $30

Add to cart Added

Trusted by 200,000+ users & 2,000+ doctors

Proven track record: 3+ million analyses delivered

Analyzes 4 Genetic Variants

Up to 1 DNA-Based, Science-Backed Recommendations

CHRNA5 (Smoking, Cognition)

$59 $29

Add to cart Added

Product features

Note: To generate your personalized report, purchase a SelfDecode DNA kit. If you already have one, you’re ready to proceed.

Understanding Your CHRNA5 (Smoking, Cognition) Variants: A DNA Gene Report

Do you ever wonder why cravings for nicotine feel stronger for some people than others? Have you noticed changes in focus, memory, or decision-making that seem tied to stress, smoking, or quitting? What if your DNA could help explain how your brain’s nicotine receptors respond—and what that means for addiction risk and cognition over time? Your CHRNA5 (Smoking, Cognition) gene variants can offer personalized insight into nicotine dependence tendencies and how smoking may interact with brain and lung health.

Key Report Highlights

This CHRNA5 (Smoking, Cognition) Gene Report analyzes 4 specific genetic variants (SNPs) connected to nicotine dependence, smoking behavior, and cognitive performance, and delivers 1 personalized recommendation based on your genotype. CHRNA5 helps build nicotinic acetylcholine receptors—key “signal receivers” that respond to acetylcholine and nicotine in the brain. A compelling finding from research is that certain CHRNA5/CHRNA3-region variants are consistently associated with heavier smoking and higher dependence risk, helping explain why nicotine can feel more reinforcing for some individuals.

Personalized, Actionable Recommendations

Your results translate your CHRNA5 (Smoking, Cognition) genotype into personalized, actionable guidance—so you’re not just reading genetics, you’re using it. This report includes 1 tailored drug-focused recommendation designed to support safer, more effective decision-making with a clinician. For example, your report may highlight whether evidence suggests you could be more likely to benefit from specific smoking-cessation pharmacotherapy options (or need closer monitoring for side effects), and it may flag genotype-linked patterns (like higher dependence risk) that can inform the intensity and structure of a quit plan discussed with your healthcare provider.

User-Friendly Format and Trust

With actionable and easy-to-understand recommendations, the report is designed for seamless integration into your daily life. Its user-friendly format ensures accessibility, making complex genetic data understandable and practical for users at all levels of familiarity with genetic information.

The report is rooted in accuracy and reliability, backed by comprehensive scientific research from reputable sources. It has garnered the trust of over 150,000 users and 1,000+ healthcare professionals. Furthermore, the report complies with HIPAA and GDPR, ensuring your privacy and security are prioritized.

Getting Started

To embark on this journey, simply purchase a DNA kit for an easy at-home sample collection, guaranteeing a hassle-free process. Delve into a personalized approach to wellness and equip yourself with actionable insights to enrich your life and health.

Product FAQs

: CHRNA5 provides instructions for making part of a nicotinic acetylcholine receptor—one of the brain’s key receptor systems for acetylcholine signaling. These receptors also respond to nicotine, which can temporarily stimulate attention and alertness. Because CHRNA5 helps shape how strongly these receptors function, it can influence how the brain experiences nicotine and how reinforcing smoking may feel.
: CHRNA5 is important because certain variants in and around this gene (including nearby receptor genes in the same region) are linked in research to higher risk of heavy smoking and nicotine dependence, as well as smoking-related lung conditions such as COPD and lung cancer. Some of these variants are also associated with reduced cognitive performance. While nicotine can briefly boost cognition by activating these receptors, long-term smoking is associated with worsening brain and respiratory health—making CHRNA5 a valuable marker for understanding risk and supporting prevention or cessation strategies.
: Based on your CHRNA5 (Smoking, Cognition) results, you’ll receive 1 personalized recommendation focused on drug-related guidance that can be taken to a clinician for shared decision-making. This may include genotype-informed considerations for smoking-cessation medications, guidance on when to seek medical support (especially if dependence risk appears elevated), and practical next steps to align treatment choices with your biology and health goals.
: CHRNA5 affects the function of nicotinic acetylcholine receptors, which are activated by both acetylcholine (a natural brain messenger) and nicotine. Research has found that certain variants in the CHRNA5/CHRNA3 region are associated with heavier smoking and greater nicotine dependence. One proposed mechanism is that reduced receptor activity can blunt normal signaling, leading some individuals to seek more nicotine stimulation (for example, smoking more) to achieve the same perceived effect—raising dependence risk and increasing exposure to smoking-related toxins.
: A CHRNA5 DNA report identifies which versions (alleles) you carry at key SNPs studied in relation to smoking behavior, nicotine dependence, and cognitive outcomes. This report analyzes 4 variants and interprets them in a health context, helping you understand potential tendencies—such as higher likelihood of dependence or differences in cognitive impact associated with smoking. It also converts your genotype into 1 personalized, drug-focused recommendation you can discuss with a healthcare professional to support more individualized smoking-cessation planning.

WHY SELFDECODE?

Empowering Your Well-being Journey

This personalized health report is powered by SelfDecode's cutting-edge AI technology, designed to unlock a deeper understanding of your health potential. We're committed to providing you with the most accurate and actionable insights to guide your well-being journey.

Most Accurate
Polygenic Risk Scoring

We leverage cutting-edge algorithms and analyze a massive dataset of 2 million people to deliver the most precise assessment of your genetic health predispositions. Our advanced approach takes into account your ancestry - which is often overlooked by other methods - to provide you with the most accurate risk assessment. This ensures that the risk scores you receive are based on the latest scientific evidence and are truly personalized to your genetic makeup.

Cutting-Edge AI &
Machine Learning

We have invested 20 million dollars developing our AI and machine learning models. Our patent-pending technology provides you with the most personalized health insights and recommendations by taking into account your unique DNA, lifestyle, labs, symptoms, conditions and health goals. This empowers you to make informed decisions tailored to your specific needs.

Analyzes 200 Million Variants & Sophisticated Recommendation Engine

We go beyond the basics by analyzing a staggering 200 million genetic variants to provide the most comprehensive picture of your health potential. Our sophisticated recommendation engine leverages this deep analysis to provide personalized and actionable insights to optimize your well-being journey.

Built by Leading
Scientists & Engineers

A dedicated team of over 60 scientists and engineers is continuously innovating and developing our technology, ensuring it remains at the forefront of personalized health.

Reviews

Rated 4.70 out of 5 based on 10 customer ratings

4.7 (11 reviews)

Share your thoughts

If you've used this product, share your thoughts with other customers

Only customers who purchased this product can leave reviews

Alex J.

Rated 3 out of 5
Useful guidance, but the science section felt a bit dense and I wanted clearer next steps for non-smokers.
Shanice B.

Rated 5 out of 5
As a grad student, I kept using nicotine pouches because they felt like a shortcut to concentration, but I also noticed my recall was getting worse during long study blocks. The CHRNA5 (Smoking, Cognition) report connected those dots for me without sounding preachy. It explained why I might be more sensitive to nicotine dependence and how that can spill into attention and cognitive stamina. The section on Nicotine Replacement Therapy helped me plan a taper with my clinician instead of white knuckling it. Two months later, cravings are quieter and my study sessions feel steadier.
Luz W.

Rated 5 out of 5
I never write reviews but this helped me way more than expected. Got clear info about my body and what might work for me. Gave it to my doctor too. Actually worth the time.
Deshawn T.

Rated 4 out of 5
CHRNA5 clarified my nicotine focus.
Juliana V.

Rated 5 out of 5
Tenho 33 anos e parei de fumar duas vezes, mas sempre voltava quando o trabalho apertava e minha cabeça ficava lenta. O relatório CHRNA5 (Smoking, Cognition) foi a primeira coisa que ligou, de forma clara, a parte de craving com a parte de foco e memória. Gostei que ele não ficou só no “pare de fumar”, ele sugeriu conversar com médico sobre Terapia de Reposição de Nicotina e trouxe dicas práticas para reduzir gatilhos e organizar o sono. Em três semanas, consegui manter a abstinência e minha concentração no período da manhã melhorou muito.

1 2 3

CHRNA5 (Smoking, Cognition)

Product features

Understanding Your CHRNA5 (Smoking, Cognition) Variants: A DNA Gene Report

Key Report Highlights

Personalized, Actionable Recommendations

User-Friendly Format and Trust

Getting Started

Product FAQs

What does the CHRNA5 (Smoking, Cognition) gene do?

Why is the CHRNA5 (Smoking, Cognition) gene important?

What can I do based on my CHRNA5 (Smoking, Cognition) results?

How is the CHRNA5 (Smoking, Cognition) gene linked to nicotine addiction and smoking intensity?

What do I learn from CHRNA5 (Smoking, Cognition) genetic testing in a DNA report?

WHY SELFDECODE?

Empowering Your Well-being Journey

Most AccuratePolygenic Risk Scoring

Cutting-Edge AI &Machine Learning

Analyzes 200 Million Variants & Sophisticated Recommendation Engine

Built by Leading Scientists & Engineers

Reviews

Related Products

Most Accurate
Polygenic Risk Scoring

Cutting-Edge AI &
Machine Learning

Built by Leading
Scientists & Engineers